| Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications GK Patel, MA Khan, H Zubair, SK Srivastava, M Khushman, S Singh, ... Scientific reports 9 (1), 5335, 2019 | 492 | 2019 |
| CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy S Singh, SK Srivastava, A Bhardwaj, LB Owen, AP Singh British journal of cancer 103 (11), 1671-1679, 2010 | 282 | 2010 |
| Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK GK Patel, MA Khan, A Bhardwaj, SK Srivastava, H Zubair, MC Patton, ... British journal of cancer 116 (5), 609-619, 2017 | 239 | 2017 |
| Multifaceted role of matrix metalloproteinases (MMPs) D Singh, SK Srivastava, TK Chaudhuri, G Upadhyay Frontiers in molecular biosciences 2, 19, 2015 | 226 | 2015 |
| MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells SK Srivastava, A Bhardwaj, S Singh, S Arora, B Wang, WE Grizzle, ... Carcinogenesis 32 (12), 1832-1839, 2011 | 212 | 2011 |
| An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB-and hypoxia-inducible … S Arora, A Bhardwaj, S Singh, SK Srivastava, S McClellan, CS Nirodi, ... Journal of Biological Chemistry 288 (29), 21197-21207, 2013 | 205 | 2013 |
| Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells S Arora, A Bhardwaj, SK Srivastava, S Singh, S McClellan, B Wang, ... PloS one 6 (6), e21573, 2011 | 146 | 2011 |
| CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase-and Akt kinase-mediated activation of … AP Singh, S Arora, A Bhardwaj, SK Srivastava, MP Kadakia, B Wang, ... Journal of Biological Chemistry 287 (46), 39115-39124, 2012 | 143 | 2012 |
| Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis R Kanchanapally, SK Deshmukh, SR Chavva, N Tyagi, SK Srivastava, ... International journal of nanomedicine, 531-541, 2019 | 118 | 2019 |
| Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells … SK Deshmukh, SK Srivastava, A Bhardwaj, AP Singh, N Tyagi, ... Oncotarget 6 (13), 11231, 2015 | 114 | 2015 |
| Racial disparities in prostate cancer: a molecular perspective. SAP Bhardwaj A, Srivastava SK, Khan MA, Prajapati VK, Singh S, Carter JE Front Biosci (Landmark Ed) 22, 772-782, 2017 | 101* | 2017 |
| MicroRNAs in gynecological cancers: Small molecules with big implications SK Srivastava, A Ahmad, H Zubair, O Miree, S Singh, RP Rocconi, ... Cancer letters 407, 123-138, 2017 | 97 | 2017 |
| p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling. SS Tyagi N, Marimuthu S, Bhardwaj A, Deshmukh SK, Srivastava SK, Singh AP ... Cancer Lett, 2016 | 97 | 2016 |
| Synthesis, characterization, and evaluation of poly (D, L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy SAP Arora S, Swaminathan SK, Kirtane A, Srivastava SK, Bhardwaj A, Singh S ... Int J Nanomedicine 9, 2933-42, 2014 | 96 | 2014 |
| Comparative analysis of the relative potential of silver, Zinc-oxide and titanium-dioxide nanoparticles against UVB-induced DNA damage for the prevention of skin carcinogenesis N Tyagi, SK Srivastava, S Arora, Y Omar, ZM Ijaz, ALG Ahmed, ... Cancer letters 383 (1), 53-61, 2016 | 84 | 2016 |
| Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance SK Srivastava, S Arora, C Averett, S Singh, AP Singh BioMed research international 2015, 2015 | 84 | 2015 |
| Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy SK Deshmukh, SK Srivastava, T Poosarla, DL Dyess, NP Holliday, ... Annals of translational medicine 7 (20), 2019 | 82 | 2019 |
| CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1 A Bhardwaj, SK Srivastava, S Singh, S Arora, N Tyagi, J Andrews, ... Oncotarget 5 (22), 11490, 2014 | 75 | 2014 |
| MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and-independent pathways SK Srivastava, A Bhardwaj, S Arora, N Tyagi, S Singh, J Andrews, ... British journal of cancer 113 (4), 660-668, 2015 | 74 | 2015 |
| Hydroxytyrosol induces apoptosis and cell cycle arrest and suppresses multiple oncogenic signaling pathways in prostate cancer cells H Zubair, A Bhardwaj, A Ahmad, SK Srivastava, MA Khan, GK Patel, ... Nutrition and cancer 69 (6), 932-942, 2017 | 71 | 2017 |
Sumit AroraMedical Writing lead, Oncology Scientist, LabCorpVerified email at covance.com
